One-year clinical outcomes of BioMatrix™-Biolimus A9™ eluting stent: The e-BioMatrix multicenter post marketing surveillance registry in India

OBJECTIVE: The e-BioMatrix is a post marketing multicenter registry with an objective to evaluate the 2 year clinical safety and efficacy outcomes in patients treated with BioMatrix™ - Biolimus A9™ (BA9™) drug eluting stents (DES). BACKGROUND: Drug-eluting stents still have late-stage disadvantages...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mehta, Ashwin B., Chandra, Praveen, Dalal, Jamshed, Shetty, Prabhakar, Desai, Devang, Chocklingam, K., Prajapati, Jayesh, Kumar, Pramod, Magarkar, Vilas, Vasawada, Apurva, Goyal, B.K., Kumar, Viveka, Rao, V. Suryaprakash, Babu, Ramesh, Parikh, Pritesh, Kaul, Upendra, Patil, Aruna, Mhetre, Tushar, Rangnekar, Hrishikesh
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2013
Assuntos:
Sponsored Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3860730/
https://ncbi.nlm.nih.gov/pubmed/24206883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2013.08.031
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados